Home
Gelesis

Gelesis Market Share Analysis for April 2026

Health > Biotechnology and Pharmaceuticals

Domaingelesis.com

Year Founded2006

Employees51 - 200

Annual Revenue$10M - $15M

Gelesis

Gelesis (including company regionals)

gelesis.com

See more website traffic and engagement information

Gelesis Revenue up to April 2026 is 10M - 15M

revenue generated by Gelesis top domains

Gelesis top domains revenue over 3 years

Revenue for Gelesis top domains

gelesis.com10M - 15M

See more with Sales Intelligence

Total visits to Gelesis's top domains

Understand Gelesis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gelesis.com349

See more with Sales Intelligence

Avg. visit duration in Gelesis's top domains

Analyze Gelesis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

gelesis.com00:01:27

See more with Sales Intelligence

Avg. pageviews on Gelesis's top domains

See how Gelesis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gelesis.com2.74

See more with Sales Intelligence

Gelesis top competitors by domain

Top similar sites in April 2026, ranked by their affinity

orexigen.comCompany NameOrexigen Therapeutics, Inc.Employees51 - 200HQUnited States, California, La JollaAnnual revenue$25M - $50MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Gelesis

These are the website technologies, by industry, used by Gelesis top domains

Payment & Currencies (10)

Cart Functionality

Advertising (4)

Google Adsense

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

More Technologies

8

See all

News & Signals from Gelesis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGelesis Srl launches financial report for the April.Gelesis Holdings Inc's Financial Report Reveals Declining Revenue and Surging Losses Gelesis Holdings Inc, a major pharmaceutical preparations company, recently released its financial report for the April to June 30, 2023 time-frame.

NewsGelesis Srl merges with CapStar Hotel Company.But executives at the group had another concern when Gelesis was merging with Capstar Special Purpose Acquisition: losing investors.

NewsGelesis Srl hired Ali Bauerlein as Board of Directors on Jan 5th '22.(Photo: Business Wire) Gelesis, a biotherapeutics company focused on excess weight and metabolic disorders and the maker of Plenity®, announced the appointment of senior financial executive Ali Bauerlein to its Board of Directors.